DeepMed Research

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Cell Phone Reminders Intervention

Not Applicable

Completed

Conditions: HIV Infections
HAART Non-Adherence
HIV

Interventions: Behavioral: Cell Phone Intervention

First Posted Date: 2010-01-14

Last Posted Date: 2017-02-28

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 43

Registration Number: NCT01049568

Locations: 🇺🇸
Childrens Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Diagnostic and Treatment Center, Fort Lauderdale, Florida, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 2 locations

Preventative Misconception Intervention

Not Applicable

Completed

Conditions: HIV
HIV Infections

Interventions: Behavioral: 2-sided messages
Behavioral: 1-sided messages

First Posted Date: 2010-01-14

Last Posted Date: 2017-03-03

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 120

Registration Number: NCT01049139

Locations: 🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸
University of Maryland Medical School, Baltimore, Maryland, United States
🇺🇸
Mount Sinai Medical Center, New York, New York, United States

and more 1 locations

Treatment for Depression Among HIV-Infected Youth

Not Applicable

Completed

Conditions: HIV
Depression
HIV Infections

Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management
Behavioral: TAU - Treatment as Usual

First Posted Date: 2010-01-14

Last Posted Date: 2017-02-28

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 42

Registration Number: NCT01049789

Locations: 🇺🇸
St. Jude Children's Research Center, Memphis, Tennessee, United States
🇺🇸
USF College of Medicine, Tampa, Florida, United States
🇺🇸
The Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 1 locations

Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

Phase 2

Terminated

Conditions: Pulmonary Hypertension

Interventions: Drug: Placebo
Drug: Warfarin

First Posted Date: 2009-12-21

Last Posted Date: 2016-05-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 3

Registration Number: NCT01036802

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Pre-Exposure Prophylaxis in YMSM

Phase 2

Completed

Conditions: HIV

Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP
Drug: Placebo
Behavioral: Many Men, Many Voices (3MV)

First Posted Date: 2009-12-17

Last Posted Date: 2017-04-17

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 68

Registration Number: NCT01033942

Locations: 🇺🇸
Childrens Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital, Chicago, Illinois, United States

Mechanisms Underlying Drug-Diet Interactions

Not Applicable

Completed

Conditions: Pharmacokinetics

Interventions: Drug: warfarin, vitamin K, midazolam

First Posted Date: 2009-12-17

Last Posted Date: 2009-12-17

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 19

Registration Number: NCT01034124

Locations: 🇺🇸
UNC-Chapel Hill General Clinical Research Center, Chapel Hill, North Carolina, United States

ID & Testing in Male Partners

Completed

Conditions: HIV

First Posted Date: 2009-12-17

Last Posted Date: 2023-04-12

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 177

Registration Number: NCT01033812

Locations: 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital, Chicago, Illinois, United States
🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Hypertonic Saline
Drug: Placebo

First Posted Date: 2009-12-15

Last Posted Date: 2017-03-03

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 23

Registration Number: NCT01031706

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)

Not Applicable

Completed

Conditions: Psychosis

Interventions: Other: ICBT Program

First Posted Date: 2009-12-09

Last Posted Date: 2013-01-15

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 35

Registration Number: NCT01027962

Locations: 🇺🇸
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders

Phase 4

Completed

Conditions: Autism Spectrum Disorder

Interventions: Drug: Aripiprazole

First Posted Date: 2009-12-09

Last Posted Date: 2014-03-11

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 13

Registration Number: NCT01028820

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy